论文部分内容阅读
目的:探究支气管哮喘急性发作应用生脉注射液辅助治疗的效果。方法:选取2015年2月至2016年2月期间本院收治的100例支气管哮喘急性发作患者,采用随机分组方式,将其分为观察组与对照组,各50例。对照组,给予常规治疗,观察组,在常规治疗基础上,联合生脉注射液辅助治疗,对比两组患者治疗效果。结果:观察组治疗总有效率为94%,对照组为78%,观察组明显高于对照组,差异显著,具有统计学意义(P<0.05)。结论:针对支气管哮喘患者,急性发作时,在常规治疗基础上,联合生脉注射液治疗,效果显著,值得广泛推广。
Objective: To investigate the effect of Shengmai injection in the treatment of acute exacerbation of bronchial asthma. Methods: A total of 100 patients with acute bronchial asthma who were admitted to our hospital from February 2015 to February 2016 were randomly divided into observation group and control group, with 50 cases in each group. Control group, given conventional treatment, observation group, on the basis of routine treatment, combined with Shengmai injection adjuvant therapy, compared the therapeutic effect of two groups of patients. Results: The total effective rate of the observation group was 94%, while that of the control group was 78%. The observation group was significantly higher than the control group, with significant difference (P <0.05). Conclusion: For patients with bronchial asthma, acute attack, on the basis of conventional treatment, combined with Shengmai injection, the effect is significant, it is worth widely disseminated.